Related Articles
Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non‑small cell lung cancer
Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells